Literature DB >> 23806164

Contact dermatitis: facts and controversies.

Ronni Wolf1, Edith Orion2, Eleonora Ruocco3, Adone Baroni3, Vincenzo Ruocco3.   

Abstract

The history of contact dermatitis (CD) is inseparable from the history of the patch test, and the patch test is inseparable from the pioneer in the field, Josef Jadassohn (1860-1936). Despite the fact that we have been diagnosing, treating, and investigating the condition for more than 100 years, there are still many unsolved questions and controversies, which show no signs of coming to an end in the foreseeable future. This contribution reviews and highlights some of the disagreements and discrepancies associated with CD. For example: • What is the real sensitizer in balsam of Peru, one of the most common allergens, and what, if any, is the value of a low-balsam diet? • Is benzalkonium chloride, which has well-known and undisputed irritant properties, a contact allergen as well? • Is cocamidopropyl betaine (CABP) a common contact allergen and what is the actual sensitizer in CABP allergy the molecule itself, or impurities, or intermediaries in its synthesis? • How can the significant differences in the prevalence of sensitization of formaldehyde (FA, a common cause of contact allergy) between the United States (8%-9%) and Europe (2%-3%) be explained? • What is the relationship between formaldehyde releasers (FRs) allergy and an FA allergy? Should we recommend that FA-allergic patients also avoid FRs, and, if so, to what extent? • What is the true frequency of lanolin allergy? This issue remains enigmatic despite the expenditure of thousands of dollars and the innumerable hours spent investigating this subject. • What is the basis behind the so-called "lanolin paradox"? This label was coined in 1996 and is still a matter of controversy. • Is there such a thing as systemic CD from nickel, and, if so, to what extent? Is there a cross-reactivity or concomitant sensitization between nickel and cobalt?These are some of the controversial problems discussed. We have selected the ones that we consider to be of special interest and importance to the practicing dermatologist.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23806164     DOI: 10.1016/j.clindermatol.2013.01.014

Source DB:  PubMed          Journal:  Clin Dermatol        ISSN: 0738-081X            Impact factor:   3.541


  6 in total

Review 1.  The Role of Textiles in Dermatitis: An Update.

Authors:  Motunrayo Mobolaji-Lawal; Susan Nedorost
Journal:  Curr Allergy Asthma Rep       Date:  2015-04       Impact factor: 4.806

Review 2.  Immediate and Delayed Hypersensitivity Reactions to Corticosteroids: Evaluation and Management.

Authors:  Iris M Otani; Aleena Banerji
Journal:  Curr Allergy Asthma Rep       Date:  2016-03       Impact factor: 4.806

3.  Contact dermatitis: a historical perspective.

Authors:  Clinton Enos; Massimo Fioranelli; Katlein França; David Castillo; Torello Lotti; Uwe Wollina; Maria Grazia Roccia
Journal:  Wien Med Wochenschr       Date:  2017-03-29

4.  Human T cell response to CD1a and contact dermatitis allergens in botanical extracts and commercial skin care products.

Authors:  Sarah Nicolai; Marcin Wegrecki; Tan-Yun Cheng; Elvire A Bourgeois; Rachel N Cotton; Jacob A Mayfield; Gwennaëlle C Monnot; Jérôme Le Nours; Ildiko Van Rhijn; Jamie Rossjohn; D Branch Moody; Annemieke de Jong
Journal:  Sci Immunol       Date:  2020-01-03

5.  Both children and adult patients with difficult-to-treat atopic dermatitis have high prevalences of concomitant allergic contact dermatitis and are frequently polysensitized.

Authors:  M Boonstra; T Rustemeyer; M A Middelkamp-Hup
Journal:  J Eur Acad Dermatol Venereol       Date:  2018-04-30       Impact factor: 6.166

Review 6.  Tumor-Treating Fields in Glioblastomas: Past, Present, and Future.

Authors:  Xiaopeng Guo; Xin Yang; Jiaming Wu; Huiyu Yang; Yilin Li; Junlin Li; Qianshu Liu; Chen Wu; Hao Xing; Penghao Liu; Yu Wang; Chunhua Hu; Wenbin Ma
Journal:  Cancers (Basel)       Date:  2022-07-28       Impact factor: 6.575

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.